4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES

(19)

(11)

EP 1 416 935 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	27.08.2008 Bulletin 2008/35

(45)	Mention of the grant of the patent:
	12.03.2008 Bulletin 2008/11

(21)	Application number: 02758437.4

(22)	Date of filing: 06.08.2002

(51)

International Patent Classification (IPC):

A61K 31/519^(2006.01)
A61P 35/00^(2006.01)

C07D 487/04^(2006.01)

(86)	International application number:
	PCT/EP2002/008780

(87)	International publication number:
	WO 2003/013541 (20.02.2003 Gazette 2003/08)

(54)	4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES 4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDIN DERIVATE DERIVES DE LA 4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
	Designated Extension States:
	RO SI

(30)

Priority:

07.08.2001 GB 0119249

(43)	Date of publication of application:
	12.05.2004 Bulletin 2004/20

(73)	Proprietors:
	Novartis AG 4056 Basel (CH) Designated Contracting States: BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR Novartis Pharma GmbH 1235 Vienna (AT) Designated Contracting States: AT

(72)	Inventors:
	BOLD, Guido CH-5073 Gipf (CH) CAPRARO, Hans-Georg CH-4310 Rheinfelden (CH) CARAVATTI, Giorgio CH-4103 Bottmingen (CH) TRAXLER, Peter CH-4124 Schönenbuch (CH)

(74)	Representative: de Weerd, Petrus G.W. et al
	Novartis International AG Corporate Intellectual Property 4002 Basel 4002 Basel (CH)

(56)

References cited: :

WO-A-97/02266

WO-A-98/07726

DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CARAVATTI, G. ET AL: "Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tyrosine kinase" retrieved from STN Database accession no. 136:318825 XP002219341 & ACS SYMPOSIUM SERIES (2001), 796(ANTICANCER AGENTS), 231-244 ,

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).